STOCK TITAN

Insider sale and equity awards listed at Cognex (NASDAQ: CGNX) — 14,881 shares sold

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

CGNX filed a Form 144 notice reporting proposed sales of common stock and related equity awards. The filing lists recent 02/12/2026 sales by Laura Ann MacDonald of 14,881 shares for $850,554.

The filing also lists RSU releases (sizes: 837, 542, 500, 333 shares) and multiple option grants with specified share counts and settlement/exercise dates, including grants of 6,634, 15,080, 12,196, 17,000, 30,000, and 15,000 shares as shown.

Positive

  • None.

Negative

  • None.

Insights

Filing lists proposed sales plus vested RSU settlements and multiple option grants.

The notice records an actual sale by Laura Ann MacDonald of $850,554 for 14,881 shares on 02/12/2026 and enumerates several RSU releases and option grants with explicit share counts and dates.

Stakeholders should note these are disclosure items about planned or completed transactions; cash‑flow treatment and any selling plan details are not shown in the excerpt.

Sale by Laura Ann MacDonald 14,881 shares Sale date <date>02/12/2026</date>
Proceeds reported for that sale $850,554 Sale date <date>02/12/2026</date>
RSU release example 837 shares RSU Release <date>02/22/2024</date>
RSU release example 542 shares RSU Release <date>02/22/2023</date>
Option grant example 30,000 shares Option Granted (grant date listed) <date>05/11/2026</date>
Option grant example 17,000 shares Option Granted (grant date listed) <date>05/11/2026</date>
Option grant example 15,080 shares Option Granted - 2/20/2024 listed with <date>05/11/2026</date>
RSU Release financial
"Settlement of vested Restricted Stock Unit award"
Restricted Stock Unit financial
"Settlement of vested Restricted Stock Unit award"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Option Granted financial
"Option Granted 2/18/2025 and other grant dates shown"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did CGNX disclose in the Form 144 filing?

The filing discloses proposed sales of common stock and equity‑based awards. It records a sale of 14,881 shares for $850,554 on 02/12/2026 and lists multiple RSU releases and option grants with stated share counts and dates.

How many shares did Laura Ann MacDonald sell (CGNX) in the past three months?

Laura Ann MacDonald sold 14,881 shares on 02/12/2026 for $850,554. This transaction is presented in the filing's "Securities Sold During The Past 3 Months" section as a completed sale.

Which equity awards are listed in the CGNX Form 144?

The filing lists RSU releases and multiple option grants. RSU release counts include 837, 542, 500, and 333 shares; option grant counts include several specific share amounts and settlement dates shown in the excerpt.

Does the Form 144 show proceeds treatment or selling plan details for CGNX?

The excerpt does not provide explicit proceeds allocation or detail a selling plan. The filing lists transactions and award settlements but does not state how proceeds are to be used or whether sales were under a prearranged plan.

Are the option grant share counts in CGNX's filing exercised or outstanding?

The filing lists option grants with stated dates and share counts (for example, 30,000, 17,000, 15,080), but the excerpt does not explicitly label these as exercised or remaining outstanding; they are shown with their grant/settlement dates.